Intelsius is proud to announce its recent partnership with Central Pharma to support the enhancement of the cell and gene therapy (CGT) industry.
Central Pharma are a specialised provider of manufacturing, packaging and storage for the CGT and wider biopharma industries. The partnership will see the Intelsius ORCA range being utilised to expand Central Pharma’s current product offerings to improve the efficiency and safety of the CGT industry worldwide.
“We are proud to partner with Central Pharma so we can continue to strengthen our global offering and better support the cell and gene therapy industry where temperature control, safety, and security are of utmost importance,” said David Walsh, CEO of Intelsius.
To read more about the partnership, click here. To read more about the Intelsius ORCA Range, click here.
